Depression and anxiety disorders in chronic hemodialysis patients

Depression and anxiety disorders in chronic hemodialysis patients
复制标题

DOI:
10.1192/j.eurpsy.2021.633
复制
发表时间:
2021-08-13
影响因子:
7.8
通讯作者:
Zarrouk, L.
Zarrouk, L.
中科院分区:
医学2区
文献类型:
--
作者:
Bouali, W.;Gniwa, R. Omezzine;Ben Soussia, R.;Mohamed, A. Hadj;Zarrouk, L.

文献摘要

被引文献

相似文献

抑郁和焦虑是终末期肾病患者最常见的共病之一。它们在血液透析(HD)患者中未被充分认识。本研究的目的是评估血液透析患者中抑郁和焦虑障碍的患病率及其相关因素。 一项横断面研究,包括2016年12月至2017年1月在突尼斯Mahdia大学医学中心透析室接受血液透析的患者。一个标准的自我管理的量表-医院焦虑和抑郁量表(HADS)被用于研究中,以衡量研究人群中焦虑和抑郁的存在和严重程度。收集了55例患者的资料。总体而言,32.7%的患者报告抑郁,23.6%报告焦虑。症状中,抑郁症与糖尿病、高血压和透析时间显著相关(p<0.05)。关于焦虑,这种显著相关性仅与透析持续时间有关。目前的研究表明,血液透析患者抑郁和焦虑的患病率是重要的,并与临床变量相关,因此应考虑有效的心理健康干预措施,并应调查这些干预措施的影响。
Depression and anxiety are among the most common comorbid illnesses in people with end-stage renal disease. They are under-recognized in hemodialysis (HD) patients. The aim of this study was to assess the prevalence of depression and anxiety disorders among HD patients and its associated factors. A cross-sectional study including patients on hemodialysis at the dialysis unit of the University Medical Center of Mahdia, Tunisia, conducted from December 2016 to January 2017. A standard self-administered questionnaire-the Hospital Anxiety and Depression Scale (HADS) was used in the study to measure the presence and severity of anxiety and depression in the study population. were collated from 55 patients. Overall, 32.7% of patients reported depression and 23.6% reported anxiety. Among symptoms, depression had a significant correlation with diabetes, high blood pressure, and duration of dialysis (p<0.05). Regarding anxiety, this significant correlation was only seen with the duration of dialysis. The current study showed that the prevalence of depression and anxiety in hemodialysis patients is important and correlates with clinical variables, so effective interventions for mental health should be taken into consideration and the impact of these interventions should be investigated.